|
|
| Catalog Number |
D138503 |
| Medical Device Problem Code |
Fluid/Blood Leak (1250)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
11/06/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
| |
|
Event or Problem Description
|
|
It was reported that a patient underwent an idiopathic ventricular tachycardia (idvt) ablation procedure and the vizigo® sheath was leaking back blood.It was reported that during the procedure, while exchanging catheters, it was noticed that the hemostatic valve on the vizigo® sheath was leaking back blood.The vizigo® sheath was replaced, and the issue was resolved.The procedure continued with no further issues.No adverse patient consequence was reported.
|
| |
|
Additional Manufacturer Narrative
|
|
The device investigation has been completed which included performing a manufacturing record evaluation (mre).The manufacturing record evaluation was performed for lot 00002993 finished device, and no internal actions related to the reported complaint condition were identified.Since no device has been received for analysis, no product investigation could be performed, and the customer complaint cannot be confirmed.However, if the product is received in the future, the investigation will be updated as applicable.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
| |
|
Search Alerts/Recalls
|
|
|